3Ohashi H.Specific activation of Protein Kinase C by hyperglucemid in macro and microvascular.tissue of diabetic rats.(abstr)Diabetes,1989,38(suppl 2):54-57.
7Tam ZS,Seshadri S,Beiser A,et al.Plasma total cholesterol level as a rist factor for Alzheimer disease:the Framingham Study.Arch intem Med,2003,163(9):1053-1057.
3Rossing P, Hommel E, Smidt UM, et al. Impact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in IDDM patients. Diabetes, 1993,42:715-719.
4Hovind P, Tamow L, Rossing P, et al. Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes : inception cohort study. BMJ, 2004,328 : 1105.
5Hostetter TH, Rennke HG, Brenner BM. The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med, 1982,72:375-380.
6Coresh J, Astor BC, Greene T, et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis, 2003, 41:1-12.
7Hovind P, Rossing P, Tarnow L, et al. Progression of diabetic nephropathy. Kidney Int, 2001,59:702-709.
8Lurbe E, Redon J, Kesani A, et al. Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med, 2002, 347:797-805.
9Brenner BM, Meyer TW, Hostetter TH. Dietary, protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury, in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med, 1982,307:652-659.
10Bjorck S, Mulec H, Johnsen SA, et al. Renal protective effect of enalapril in diabetic nephropathy. BMJ, 1992,304:339-343.
